Skip to main content
Larry Junck, MD, Oncology, Ann Arbor, MI, University of Michigan Medical Center

LarryRichardJunckMD

Oncology • Ann Arbor, MI

Neuro-Oncology

Professor of Neurology, Univ of Michigan Medical School

Join to view full profile

Dr. Junck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Junck's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1981 - 1983
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1976 - 1977
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1976

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1980 - Present
  • CA State Medical License
    CA State Medical License 1977 - Present
  • MI State Medical License
    MI State Medical License 1983 - 2026
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Grant Support

  • ZD1839 For Recurrent/ Progressive Malig Astrocytoma, Glioblastoma, &MeningiomaNational Center For Research Resources2004
  • Phase I/II Trial Of CCI-779 (Nsc# 683864) In Patients W/ Malignant GliomaNational Center For Research Resources2004
  • Phase I/II Trial Cpt-11&Temozolomide(Temodar)In Pts.W/Malignant Glioma Umcc 0048National Center For Research Resources2004
  • Phase II Study Of Su101 For Patients With Anaplastic ASTNational Center For Research Resources2000–2002
  • Su101 Versus Procarbazine For First Relapse Patients W/ GlioblastomaNational Center For Research Resources1999–2002
  • Regional Brain Activation In Patients With Brain TumorsNational Center For Research Resources1996–2002
  • PET Growth Kinetics And Neuropathology Of Brain TumorsNational Cancer Institute1991–1994
  • PETT Studies Of Brain MetabolismNational Institute Of Neurological Disorders And Stroke1988
  • PET Studies Of Brain MetabolismNational Institute Of Neurological Disorders And Stroke1985–1987

Hospital Affiliations

Dr. Larry Junck, Dr. Larry Junck, MD, Dr. L Junck, Dr. Larry Richard Junck